| Autor: |
Pollock NR; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts 12215, USA. npollock@bidmc.harvard.edu, Kashino SS, Napolitano DR, Sloutsky A, Joshi S, Guillet J, Wong M, Nardell E, Campos-Neto A |
| Jazyk: |
angličtina |
| Zdroj: |
Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2009 Apr; Vol. 30 (4), pp. 392-5. |
| DOI: |
10.1086/596606 |
| Abstrakt: |
To evaluate the utility of the QuantiFERON-TB Gold assay for monitoring latent tuberculosis treatment efficacy, the assay was performed serially for healthcare workers receiving isoniazid therapy. After 9 months of isoniazid therapy, all of these healthcare workers remained QuantiFERON-TB Gold positive, and cellular proliferation assays revealed persistently strong purified protein derivative responses. These results do not support the use of the QuantiFERON-TB Gold assay to monitor therapy. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
